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Abstract
Background: The proportion of older patients in cardiac surgery is continuously increasing. 37%
of patients undergoing heart surgery in Germany in the year 2000 were 70 years of age and older.
We have studied the role of age as a determinant of mortality in cardiac surgery in our institutional
patient population.
Methods: We have calculated the EuroSCORE and the corresponding age-adjusted EuroSCORE
in 8769 patients who underwent heart surgery between January 1996 and January 2002 and
collected the information on the occurrence of postoperative complications and 30-days mortality.
Results: The multimorbidity increased with ascending age. Both the EuroSCORE and the age-
adjusted EuroSCORE values increased significantly with age in the whole group of patients as well
as in the group of patients who were alive 30 days after heart surgery. The incidence of
postoperative complications and 30-days mortality increased significantly with age. In patients who
died within 30 days after surgery, the EuroSCORE increased significantly with age, whereas the age-
adjusted EuroSCORE did not. The occurrence of diabetes mellitus, arterial hypertension and atrial
fibrillation, i.e., the risk factors not considered by the EuroSCORE, exhibited a significant age
dependence in our patients. The univariate analysis identified the significant dependence of 30-days
mortality on diabetes and atrial fibrillation. The stepwise logistic regression analysis showed the
dependence of mortality on diabetes.
Conclusions: On the background of the well-known age-dependent structural and functional
changes of different body organs, our data show that age is a significant risk indicator in cardiac
surgery, strongly correlating with morbidity and mortality. Consequently, special preventive and
therapeutic measures are required in clinical environment in the case of elderly patients undergoing
cardiac surgery.
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The proportion of older patients in cardiac surgery is in-
creasing as a consequence of demographic changes and
new developments in medical technology. In the year
1989, 3673 patients in the age of 70 years and over under-
went a cardiac surgical procedure in Germany, whereas in
the year 2000 the number of operated patients in this age
group increased to 35884. Thus, the proportion of pa-
tients aged 70 years and older increased from 11,2% to
36,7% [1,2].
The EuroSCORE is one of the established risk evaluation
scores in heart surgery in Europe [3–5]. In Germany, the
EuroSCORE is presently being employed as a nation-wide
quality control tool for the assessment of the 30-days
mortality risk in cardiac surgery. It is based on a logistic re-
gression model and includes all adult cardiac surgery pro-
cedures within a defined 30-days time interval. Besides
other parameters, the age above 60 years is regarded as an
independent determinant of mortality in this score sys-
tem, whereby the risk weight is increased in 5-years inter-
vals (table 1; see also  [http://www.euroscore.org/
calc.html]). We have checked the effect of age on the mor-
tality rate and the occurrence of postoperative complica-
tions in our institutional patients.
Table 1: EuroScore (4)
Variable Definition and Scoring
Patient-related factors
Age (years) Per 5 years or part thereof over 60 years 1
Gender Female 1
Chronic pulmonary disease (COPD) Long term use of bronchodilators or steroids for lung disease 1
Extracardiac arteriopathy Any one or more of the following: claudication, carotid occlu-
sion or >50% stenosis, previous or planned intervention on the 
abdominal aorta, limb arteries or carotids
2
Neurological dysfunction Disease severely affecting ambulation or day-to-day functioning 2
Previous cardiac surgery Surgery requiring opening of the pericardium 3
Serum creatinine Serum creatinine > 200 mol/l preoperatively 2
Active endocarditis Patient still on antibiotic treatment for endocarditis at time of 
surgery
3
Critical preoperative state Any one or more of the following: ventricular tachycardia or 
fibrillation or aborted sudden death, preoperative cardiac mas-
sage, preoperative ventilation before anaesthetic room, preop-
erative inotropes or intra-aortic balloon pump, preoperative 
acute renal failure (anuria or oliguria <10 ml/h)
3
Cardiac-related factors
Unstable angina Rest angina requiring intravenous nitrates until arrival in anaes-
thetic room
2
Left ventricular dysfunction Moderate or left ventricular ejection fraction 30–50% Poor or 
left ventricular ejection fraction <30%
13
Recent myocardial infarction Myocardial infarction within 90 days 2
Pulmonary hypertension Systolic pulmonary artery pressure >60 mmHg 2
Operation-related factors
Emergency Carried out on referral before the beginning of the next work-
ing day
2
Other than isolated CABG Major cardiac procedure other than or in addition to CABG 2
Surgery on thoracic aorta For disorders of ascending, arch or descending aorta 3
Postinfarction septal rupture 4
Score Risk Expected mortality (95% confidence lim-
its)
0–2 Low 1,27–1,29%
3–5 Medium 2,90–2,94%
 6 High 10,93–11,54%Page 2 of 8
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Several patient files, for instance, the databases of the de-
partments of anaesthesiology, clinical laboratory and in-
stitutional management, the database of the nation-wide
quality control in cardiac surgery, internal follow-up in-
formation files and the databases of specific groups of pa-
tients, e.g. the patients requiring haemodialysis, are
assembled in parallel in our institution. In cooperation
with the Department of Neuroinformatics at the Universi-
ty in Bielefeld, we have created a new specialized data-
base, bringing together the information from the already
existing database systems. Using this specialized database,
we have retrospectively studied a total of 8769 patients
who underwent a cardiac surgery in the time interval be-
tween January 1996 and January 2002.
According to the established EuroSCORE evaluation pro-
cedure, our patients were divided into seven age groups.
The EuroSCORE and the age-adjusted EuroSCORE values
were calculated for each patient, in the latter case by sub-
tracting the scoring points for the corresponding age
group. Thereafter, the occurrence of postoperative compli-
cations and the 30-days mortality were determined. Final-
ly, statistical analyses (Pearson' Chi square test, ANOVA)
were performed with the aim to establish the role of age
in cardiac surgery. Statistical significance was defined as p
< 0.05. In addition to the EuroSCORE parameters, we
have also determined the occurrence of arterial hyperten-
sion, diabetes mellitus, as well as atrial fibrillation in all
age groups studied. The dependence of the 30-days mor-
tality on these three variables was checked by univariate as
well as stepwise logistic regression analyses.
Results
The calculated EuroSCORE parameters in all age groups
studied, as well as the occurrence of the three additionally
determined accompanying diseases, are shown in table 2.
Highly significant age-dependent differences in the distri-
bution of the following variables were found: female gen-
der, chronic obstructive pulmonary disease (COPD), non-
cardiac atherosclerosis, neurological dysfunction, instable
angina, left ventricular ejection fraction 30–50%, non-iso-
lated coronary artery bypass grafting (CABG), thoracic
aortic surgery, arterial hypertension, diabetes and atrial fi-
brillation. Table 3 shows the EuroSCORE and the age-ad-
justed EuroSCORE values in the following three groups of
patients: 1. all patients, 2. patients who were alive 30 days
after surgery and 3. patients who died within 30 days after
surgery. Both the EuroSCORE and the age-adjusted Euro-
SCORE values increased significantly with age in the
group of all patients studied and in the group of 30-days
survivors. In the group of patients who died within 30
days after cardiac surgery, the EuroSCORE exhibited a sig-
nificant age-dependent increase, however, the age-adjust-
ed EuroSCORE value did not change significantly with
age.
Table 2: Preoperative data
Age group < 60 61–65 66–70 71–75 76–80 81–85 86–90 p value
n 2180 1539 1798 1731 1169 293 58 ---
Female 15,6% 22,2% 27,0% 38,1% 45,9% 59,7% 56,9% < 0,005
COPD 2,8% 3,8% 4,6% 5.0% 5,3% 7,2% 8,6% < 0,005
Extracardiac arteriopathy 10,6% 15,7% 17,7% 19,2% 18,8% 15,7% 20,7% < 0,005
Neurological dysfunction 2,6% 3,0% 4,7% 4,3% 4,0% 5,5% 1,7% 0,006
Previous cardiac surgery 4,8% 4,8% 5,6% 4,6% 4,4% 3,1% 5,2% 0,658
Serum creatinine > 200 mol/l 1,6% 1,6% 1,2% 2,5% 1,8% 0,7% 5,2% 0,038
Active endocarditis 1,2% 0,5% 0,3% 0,7% 0,3% 0,7% 1,7% 0,014
Critical preoperative state 0,8% 0,5% 0,6% 0,7% 0,4% 1,0% 1,7% 0,777
Unstable angina 9,4% 10,7% 11,2% 9,4% 11,8% 14,0% 27,0% < 0,005
LV ejection fraction 30–50% 28,4% 28,0% 33,0% 34,4% 33,5% 37,2% 53,4% < 0,005
LV ejection fraction < 30% 4,3% 4,8% 5,6% 4,7% 5,5% 4,4% 6,9% 0,635
Recent myocardial infarct 11,1% 9,4% 9,9% 9,5% 7,4% 9,2% 3,4% 0,034
Pulmonary hypertension 5,1% 4,5% 4,5% 6,4% 6.0% 8,5% 6,9% 0,032
Emergency 1,4% 1,3% 1,1% 1,7% 1,5% 1,7% 5,2% 0,309
Other than isolated CABG 15,0% 11,4% 10,4% 12,4% 15,0% 23,5% 24,1% < 0,005
Surgery on thoracic aorta 2,6% 1,2% 1,0% 1,2% 0,5% 0,7% 0,0% < 0,005
Postinfarction septal rupture 0,0% 0,1% 0,0% 0,0% 0,0% 0,0% 0,0% 0,157
Arterial hypertension 62,2% 70,1% 74,0% 74,6% 71,7% 67,2% 100% < 0,005
Diabetes mellitus 20,1% 27,6% 28,8% 29,6% 29,9% 27,6% 17,2% < 0,005
Atrial fibrillation 2,9% 4,8% 6,1% 9,5% 9,8% 14,7% 13,8% < 0,005Page 3 of 8
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formed in the seven age groups studied and show the cor-
responding 30-days mortalities. The relative number of
coronary bypass surgeries, with a mortality rate of 1,1%,
decreased with age in our patient population, whereas the
number of aortic valve replacement procedures, either
with or without accompanying coronary grafting, in-
creased. The mortality for aortic valve replacement was
2,7% and 4,1% in the case of isolated and combined sur-
gical procedures, respectively. Table 6 shows the incidence
of postoperative complications. The 30-days mortality
and the occurrence of most postoperative complications
rose significantly with increasing age. The univariate anal-
ysis revealed a significant dependence of 30-days mortali-
ty on diabetes (p = 0,016) and atrial fibrillation (p <
0,005). The stepwise logistic regression analysis showed a
significant dependence of mortality on diabetes (p =
0,050).
Discussion
The demographic changes result in a continuously in-
creasing number of elderly patients being treated in cardi-
ac surgery departments. In Germany, there exists no
nation-wide database on the prevalence and incidence of
those accompanying diseases studied in our patient group
for the whole population, therefore, it is not possible to
compare our patients with an age-matched group of sub-
jects to determine any possible biological selection. If we
consider the age-adjusted EuroSCORE as a measure of
multimorbidity, then our data show an increase in multi-
morbidity in patients undergoing cardiac surgery with
age. A detailed analysis of the individual EuroSCORE var-
iables and the additional evaluation of other parameters
confirm that the number of accompanying diseases in pa-
tients undergoing cardiac surgery increases with age.
When compared with other age groups, the relatively
small number of patients aged 80 years and over in our
Table 3: EuroScore and age-stripped EuroScore
All patients
Age group N EuroScore Age-stripped EuroScore
< 60 2180 2,35  0,05 2,35  0,05
61–65 1539 3,45  0,06 2,45  0,06
66–70 1798 4,72  0,06 2,72  0,06
71–75 1731 6,06  0,07 3,06  0,07
76–80 1169 7,43  0,08 3,43  0,08
81–85 293 9,61  0,17 4,61  0,17
86–90 58 12,38  0,34 6,38  0,34
p value < 0,005 < 0,005
Patients surviving 30 days
Age group N EuroScore Age-stripped EuroScore
< 60 2165 2,33 + 0,05 2,33 + 0,05
61–65 1518 3,41 + 0,06 2,41 + 0,06
66–70 1770 4,69 + 0,06 2,69 + 0,06
71–75 1693 6,04 + 0,07 3,04 + 0,07
76–80 1134 7,35 + 0,08 3,35 + 0,08
81–85 276 9,54 + 0,18 4,54 + 0,18
86–90 55 12,44 + 0,33 6,44 + 0,33
p value < 0,005 < 0,005
Patients dead during the first 30 postoperative days
Age group absolute relative EuroScore Age-stripped EuroScore
< 60 15 0,7% 5,13  0,95 5,13  0,95
61–65 21 1,4% 6,48  0,91 5,48  0,91
66–70 28 1,6% 6,68  0,57 4,68  0,57
71–75 38 2,2% 7,37  0,49 4,37  0,49
76–80 35 3,0% 9,91  0,61 5,91  0,61
81–85 17 5,8% 10,82  0,56 5,82  0,56
86–90 3 5,2% 11,33  3,38 5,33  3,38
p value < 0,005 < 0,005 0,519Page 4 of 8
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drawn from the data obtained in this specific group of pa-
tients. Alexander et al. [6] found the following significant
differences between a group of 60161 patients aged below
80 years and undergoing an isolated CABG in comparison
with a group of 4306 patients 80 years of age and older:
female gender 28,2% vs. 44,1%, COPD 16,0% vs 14,1%,
diabetes mellitus 29,5% vs. 23,0%, renal insufficiency
4,8% vs. 8,0%, chronic cardiac failure 11,7% vs. 19,4%,
cerebrovascular disease 10,4% vs. 18,7%, peripheral vas-
cular disease 13,7% vs. 16,4%, coronary triple vessel dis-
ease 64,3% vs. 70,4%. Also other studies indicate that age
increases the multimorbidity in patients undergoing heart
surgery [7,8]. If we take this increasing multimorbidity
into account, then the rise in 30-days mortality and occur-
rence of most postoperative complications with age, ob-
served in our patient population, is not an unexpected
result. Moreover, it is in harmony with the results of other
research groups [6–9]. Also the reduction of the number
of isolated coronary surgeries with increasing age, ob-
served in our group of patients, corresponds with the find-
ings of other authors [6,8]. This surgical procedure is
associated with a lower overall mortality when compared
with the valve replacement and repair, as well as com-
bined surgical procedures, nevertheless, it contributes to
the increasing mortality with age. In the year 2000, the
mortality for isolated CABG in Germany was 2,9%, 3,3%
for isolated aortic valve replacement and 6,0% for simul-
taneous coronary bypass surgery with accompanying aor-
tic valve replacement [2]. This issue is considered in the
Table 4: Operative procedures
Age group < 60 61–65 65–70 71–75 76–80 81–85 86–90
n % n % n % n % n % n % n %
All procedures 2180 100 1539 100 1798 100 1731 100 1169 100 293 100 58 100
CABG 1554 71,28 1126 73,16 1295 72,02 1185 68,46 739 63,22 132 45,05 26 44,83
AVR 145 6,65 100 6,49 117 6,51 124 7,16 127 10,86 52 17,74 10 17,24
AVR+CABG 62 2,84 56 3,64 102 5,67 118 6,82 128 10,95 60 20,48 13 22,41
MVR 75 3,44 36 2,34 32 1,78 37 2,14 20 1,71 9 3,07 2 3,45
AVR+MVR 10 0,46 5 0,32 5 0,28 15 0,87 7 0,59 1 0,34 0 0
MVR+CABG 22 1,01 15 0,97 29 1,61 28 1,62 27 2,31 6 2,05 0 0
OPCAB 98 4,49 74 4,81 69 3,84 73 4,22 30 2,57 18 6,14 4 6,89
Other 214 9,82 127 8,25 149 8,29 151 8,72 91 7,78 15 5,12 3 5,17
CABG: coronary artery bypass grafting, AVR: aortic valve replacement, MVR: mitral valve repair or replacement, OPCAB: off-pump coronary artery 
bypass grafting, Other: redo procedures, surgery on thoracic aorta, repair of atrial septal defect, repair of postinfarction septal defect
Table 5: 30-days mortality
Age group < 60 61–65 66–70 71–75 76–80 81–85 86–90 p value All age 
groups
All procedures 0,7% 1,4% 1,6% 2,2% 3,0% 5,8% 5,2% < 0,005 1,8%
CABG 0,5% 1,0% 0,8% 1,4% 2,4% 1,5% 3,8% < 0,005 1,1%
AVR 0,7% 3,0% 3,4% 1,6% 3,1% 7,7% 0 0,206 2,7%
AVR+CABG 0 1,8% 3,9% 4,2% 2,3% 11,7% 15,4% 0,014 4,1%
MVR 1,3% 2,8% 3,1% 5,4% 15,0% 11,1% 0 0,188 4,3%
AVR+MVR 10,0% 0 0 6,7% 14,3% 100% --- 0,049 9,3%
MVR+CABG 9,1% 0 0 3,6% 3,7% 0 --- 0,519 3,1%
OPCAB 0 0 1,5% 2,7% 3,3% 5,6% 0 0,352 1,4%
Other 1,4% 3,9% 4,7% 6,0% 4,4% 6,7% 0 0,416 3,9%
CABG: coronary artery bypass grafting, AVR: aortic valve replacement, MVR: mitral valve repair or replacement, OPCAB: off-pump coronary artery 
bypass grafting, Other: redo procedures, surgery on thoracic aorta, repair of atrial septal defect, repair of postinfarction septal defectPage 5 of 8
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than isolated CABG".
In the patients, who died within 30 days after surgery, the
EuroSCORE rose significantly with age, however, the score
value did not show such significant changes after adjust-
ment for age. Therefore, the question arises what is the
reason for the increased mortality observed in the elderly
and, further, what other factors are concealed behind the
common variable 'age'. The following four points have to
be discussed with respect to this issue:
1. Several diseases, e.g., COPD, peripheral atherosclerosis
or renal insufficiency, are considered in the EuroSCORE
analysis, however, the stage of the respective diseases and
the intensity of the pathological processes, both of which
are influenced by the time factor, are not taken into ac-
count. Therefore, the different intensity and duration of
the mentioned diseases may be hidden in the EuroSCORE
parameter 'age'.
2. The EuroSCORE risk evaluation system has been de-
rived from a large database of cardiac surgical patients.
Some diseases were not identified as being relevant with
respect to mortality in this large patient population by the
multivariate analysis and, therefore, were not considered
during the generation of the EuroSCORE list of risk fac-
tors. We have studied the dependence of mortality on ar-
terial hypertension, diabetes and atrial fibrillation, i.e.,
the three factors not included in the EuroSCORE system.
All three factors exhibited significant differences in their
respective age-related distributions. The univariate analy-
sis determined a significant dependence of the 30-days
mortality on diabetes and atrial fibrillation. The multivar-
iate analysis revealed the dependence of the 30-days mor-
tality on diabetes. The effect of such factors, that are not
separately considered in the EuroSCORE analysis, may
also partly contribute to the parameter 'age'.
3. The following factors are taken into account by the Eu-
roSCORE system to characterize the cardiac status: insta-
ble angina, left ventricular ejection fraction 30–50% or
<30%, myocardial infarction within preceding 90 days be-
fore surgery, systolic pulmonary artery pressure >60 mm-
Hg. These patient data guarantee objective data
acquisition and good comparability among hospitals with
differing personnel and technology backgrounds and ad-
equately describe certain aspects of the cardiac status. It
would be inappropriate to expect the EuroSCORE system
to consider in detail all characteristic features of the cardi-
ovascular system in its complexity. However, one factor,
shown to possess a high degree of diagnostic and thera-
peutic relevance in the elderly, the diastolic cardiac func-
tion [10], is not taken into account in the EuroSCORE
cardiac operative risk evaluation. Senni et al. [11] have
found out that 43% of patients with the primary diagnosis
of cardiac failure exhibited normal systolic heart function.
Other studies have shown that diastolic heart failure is
found in about 50% of elderly patients suffering from
congestive heart failure [12,13]. This means, that also this
aspect may be hidden in the EuroSCORE parameter 'age'.
Table 6: Postoperative complications
Age group < 60 61–65 66–70 71–75 76–80 81–85 86–90 p value
n 2180 1539 1798 1731 1169 293 58 ----
Pneumonia 7,8% 8,6% 9,0% 11,6% 11,7% 18,1% 6,9% < 0,005
Arrhythmia 31,6% 39,1% 48,2% 54,7% 60,5% 67,2% 70,7% < 0,005
Myocardial infarction 1,2% 1,2% 1,7% 1,8% 1,7% 2,7% 1,7% 0,493
Unstable sternum 0,3% 0,6% 1,1% 0,9% 1,1% 1,4% 5,2% 0,001
Significant pleural effusion 9,0% 11,0% 11,3% 13,5% 15,2% 16,0% 15,5% < 0,005
Significant pericardial effusion 0,6% 0,8% 0,8% 1,2% 1,5% 2,7% 1,7% 0,016
Cerebral vascular accident 1,7% 1,7% 2,1% 3,6% 3,8% 6,1% 8,6% < 0,005
Confusion 2,0% 4,2% 5,8% 9,3% 13,1% 21,2% 24,1% < 0,005
Rethoracotomy 2,6% 2,8% 3,2% 3,4% 3,3% 5,5% 5,2% 0,238
Reintubation 2,5% 3,0% 4,5% 4,4% 7,0% 7,8% 10,3% < 0,005
Resuscitation 1,8% 1,8% 2,6% 2,6% 3,0% 7,5% 1,7% < 0,005
IABP 0,7% 0,6% 0,6% 0,9% 1,1% 1,4% 0 0,622
Dialysis 1,6% 2,8% 3,0% 4,0% 6,4% 7,8% 13,8% < 0,005
Laparotomy 0,1% 0,1% 0,3% 0,1% 0,3% 0,3% 0 0,399
30-days mortality 0,7% 1,4% 1,6% 2,2% 3,0% 5,8% 5,2% < 0,005Page 6 of 8
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and functional changes in various organ systems, which
may influence the perioperative outcome. The following
age-dependent changes in the cardiovascular system have
previously been identified: dilation of large vessels, thick-
ening of vessel walls, affecting first of all the intimal layer,
loss of vessel elasticity [14–16], increase in left ventricular
afterload [17], thickening of left ventricular wall [14,18],
cardiac myocyte cell loss and increase in the amount of
myocardial collagen [19], decline in early diastolic left
ventricular filling rate [20], increased atrial contribution
to ventricular filling and larger atrial diameter [18], re-
duced adaptability of the cardiac response to different
workloads resulting from modified ventricular filling vol-
umes and changes in heart rate [17], increasing deficits in
sympathetic modulation [21], changes in myocardial cal-
cium hemostasis, affecting the excitation-contraction cou-
pling and, consequently, the myocardial contractility and
tendency to arrhythmias [22,23]. The consequence of all
the above-mentioned changes is the reduced cardiac
adaptability to workload observed in the elderly [24,25].
The age-dependent changes in other than cardiovascular
body organ systems require specific preventive and thera-
peutic measures. For instance, the well-known age-related
changes in lung structure and function (e.g., increase in
functional residual capacity and residual volume, weak-
ness of the expiratory muscles, malfunction of the airway
epithelium accompanied with increased production of
mucus, diminished tendency to cough, increased ventila-
tion-perfusion mismatch) may lead to complications in
older patients undergoing cardiac surgery. To prevent pul-
monary complications in the elderly, it is necessary to ex-
amine the lung function and to initiate chest
physiotherapy with breathing exercise already preopera-
tively. Early extubation, mobilisation, and pharmacologi-
cally supported bronchial clearance should follow
postoperatively and a dehydration of the patients should
be avoided. (A review of other therapeutic measures in
elderly cardiac surgical patients is given in [26].)
Conclusions
It can be summarized that age strongly correlates with a
cluster of risk factors and organ dysfunctions, occurring
during aging. However, the old age as such is not a dis-
ease. It is only a state characterized by a relatively high
probability of suffering from various disturbances of the
normal body function. From this point of view, age is a
risk factor strongly correlating with mortality. Because of
increased occurrence of age-related multimorbidity and
changes in organ structure and function, special attention
has to be paid to adequate therapeutic measures in elderly
patients undergoing heart surgery.
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